img

Global SARS-CoV-2 IgG (RBD) ELISA Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global SARS-CoV-2 IgG (RBD) ELISA Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global SARS-CoV-2 IgG (RBD) ELISA market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, ELISA Sets accounting for % of the SARS-CoV-2 IgG (RBD) ELISA global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Hospital segment is altered to an % CAGR throughout this forecast period.
The global key companies of SARS-CoV-2 IgG (RBD) ELISA include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences and BioMérieux, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States SARS-CoV-2 IgG (RBD) ELISA market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe SARS-CoV-2 IgG (RBD) ELISA landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global SARS-CoV-2 IgG (RBD) ELISA market. The analysts authoring the report have closely studied key strategies adopted by top players of the global SARS-CoV-2 IgG (RBD) ELISA market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global SARS-CoV-2 IgG (RBD) ELISA market. Readers of the report can become informed about current and future trends of the global SARS-CoV-2 IgG (RBD) ELISA market and how they will impact market growth during the forecast period.



By Company


R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
LOEWE Biochemica
Shenzhen YHLO Biotech
LG
Segment by Type
ELISA Sets
ELISA Kits

Segment by Application


Hospital
Clinic
Disease control and prevention system
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of SARS-CoV-2 IgG (RBD) ELISA in global and regional level.
Chapter 3Detailed analysis of SARS-CoV-2 IgG (RBD) ELISA companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SARS-CoV-2 IgG (RBD) ELISA revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 ELISA Sets
1.2.3 ELISA Kits
1.3 Market by Application
1.3.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Disease control and prevention system
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size (2018-2034)
2.2 SARS-CoV-2 IgG (RBD) ELISA Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2018-2024)
2.4 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 SARS-CoV-2 IgG (RBD) ELISA Countries Ranking by Market Size
3 SARS-CoV-2 IgG (RBD) ELISA Competitive by Company
3.1 Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players
3.1.1 Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players (2018-2024)
3.1.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Players (2018-2024)
3.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by SARS-CoV-2 IgG (RBD) ELISA Revenue
3.4 Global SARS-CoV-2 IgG (RBD) ELISA Market Concentration Ratio
3.4.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by SARS-CoV-2 IgG (RBD) ELISA Revenue in 2022
3.5 Global Key Players of SARS-CoV-2 IgG (RBD) ELISA Head office and Area Served
3.6 Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Product and Application
3.7 Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global SARS-CoV-2 IgG (RBD) ELISA Breakdown Data by Type
4.1 Global SARS-CoV-2 IgG (RBD) ELISA Historic Revenue by Type (2018-2024)
4.2 Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Revenue by Type (2024-2034)
5 Global SARS-CoV-2 IgG (RBD) ELISA Breakdown Data by Application
5.1 Global SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Application (2018-2024)
5.2 Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024)
6.2 North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2034)
6.3 North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2034)
6.4 North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024)
7.2 Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2034)
7.3 Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2034)
7.4 Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024)
8.2 Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2034)
8.3 Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2034)
8.4 Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024)
9.2 Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2034)
9.3 Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2034)
9.4 Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024)
10.2 Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2034)
10.3 Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2034)
10.4 Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 R&D Systems
11.1.1 R&D Systems Company Details
11.1.2 R&D Systems Business Overview
11.1.3 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.1.4 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.1.5 R&D Systems SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.1.6 R&D Systems Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.2.4 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.2.5 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.2.6 Thermo Fisher Scientific Recent Development
11.3 Ortho Clinical Diagnostics
11.3.1 Ortho Clinical Diagnostics Company Details
11.3.2 Ortho Clinical Diagnostics Business Overview
11.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.3.4 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.3.5 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.3.6 Ortho Clinical Diagnostics Recent Development
11.4 BD Biosciences
11.4.1 BD Biosciences Company Details
11.4.2 BD Biosciences Business Overview
11.4.3 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.4.4 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.4.5 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.4.6 BD Biosciences Recent Development
11.5 ZEUS Scientific
11.5.1 ZEUS Scientific Company Details
11.5.2 ZEUS Scientific Business Overview
11.5.3 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.5.4 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.5.5 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.5.6 ZEUS Scientific Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.6.4 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.6.5 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.6.6 Bio-Rad Laboratories Recent Development
11.7 ALPCO
11.7.1 ALPCO Company Details
11.7.2 ALPCO Business Overview
11.7.3 ALPCO SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.7.4 ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.7.5 ALPCO SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.7.6 ALPCO Recent Development
11.8 Enzo Life Sciences
11.8.1 Enzo Life Sciences Company Details
11.8.2 Enzo Life Sciences Business Overview
11.8.3 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.8.4 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.8.5 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.8.6 Enzo Life Sciences Recent Development
11.9 BioMérieux
11.9.1 BioMérieux Company Details
11.9.2 BioMérieux Business Overview
11.9.3 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.9.4 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.9.5 BioMérieux SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.9.6 BioMérieux Recent Development
11.10 LOEWE Biochemica
11.10.1 LOEWE Biochemica Company Details
11.10.2 LOEWE Biochemica Business Overview
11.10.3 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.10.4 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.10.5 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
11.10.6 LOEWE Biochemica Recent Development
11.11 Shenzhen YHLO Biotech
11.11.1 Shenzhen YHLO Biotech Company Details
11.11.2 Shenzhen YHLO Biotech Business Overview
11.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.11.4 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.11.5 Shenzhen YHLO Biotech Recent Development
11.12 LG
11.12.1 LG Company Details
11.12.2 LG Business Overview
11.12.3 LG SARS-CoV-2 IgG (RBD) ELISA Products and Services
11.12.4 LG SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
11.12.5 LG Recent Development
12 SARS-CoV-2 IgG (RBD) ELISA Market Dynamics
12.1 SARS-CoV-2 IgG (RBD) ELISA Industry Trends
12.2 SARS-CoV-2 IgG (RBD) ELISA Market Drivers
12.3 SARS-CoV-2 IgG (RBD) ELISA Market Challenges
12.4 SARS-CoV-2 IgG (RBD) ELISA Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of ELISA Sets
Table 3. Key Players of ELISA Kits
Table 4. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 6. Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 8. Global SARS-CoV-2 IgG (RBD) ELISA Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 9. Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players (2018-2024) & (US$ Million)
Table 10. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Players (2018-2024)
Table 11. Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-CoV-2 IgG (RBD) ELISA as of 2022)
Table 12. Ranking of Global Top SARS-CoV-2 IgG (RBD) ELISA Companies by Revenue (US$ Million) in 2022
Table 13. Global 5 Largest Players Market Share by SARS-CoV-2 IgG (RBD) ELISA Revenue (CR5 and HHI) & (2018-2024)
Table 14. Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Headquarters and Area Served
Table 15. Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Product and Application
Table 16. Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2018-2024) & (US$ Million)
Table 19. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2018-2024)
Table 20. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 21. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2024-2034)
Table 22. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2018-2024)
Table 24. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2024-2034)
Table 26. North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024) & (US$ Million)
Table 27. North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2024) & (US$ Million)
Table 28. North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2024-2034) & (US$ Million)
Table 29. North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2024) & (US$ Million)
Table 30. North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2024-2034) & (US$ Million)
Table 31. North America SARS-CoV-2 IgG (RBD) ELISA Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 32. North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2018-2024) & (US$ Million)
Table 33. North America SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2024-2034) & (US$ Million)
Table 34. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024) & (US$ Million)
Table 35. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2024) & (US$ Million)
Table 36. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2024-2034) & (US$ Million)
Table 37. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2024) & (US$ Million)
Table 38. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2024-2034) & (US$ Million)
Table 39. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 40. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2018-2024) & (US$ Million)
Table 41. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2024-2034) & (US$ Million)
Table 42. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024) & (US$ Million)
Table 43. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2024) & (US$ Million)
Table 44. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2024-2034) & (US$ Million)
Table 45. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2024) & (US$ Million)
Table 46. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2024-2034) & (US$ Million)
Table 47. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 48. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Region (2018-2024) & (US$ Million)
Table 49. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue by Region (2024-2034) & (US$ Million)
Table 50. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024) & (US$ Million)
Table 51. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2024) & (US$ Million)
Table 52. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2024-2034) & (US$ Million)
Table 53. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2024) & (US$ Million)
Table 54. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2024-2034) & (US$ Million)
Table 55. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 56. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2018-2024) & (US$ Million)
Table 57. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2024-2034) & (US$ Million)
Table 58. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Company (2021-2024) & (US$ Million)
Table 59. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2018-2024) & (US$ Million)
Table 60. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Type (2024-2034) & (US$ Million)
Table 61. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2018-2024) & (US$ Million)
Table 62. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Application (2024-2034) & (US$ Million)
Table 63. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 64. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2018-2024) & (US$ Million)
Table 65. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue by Country (2024-2034) & (US$ Million)
Table 66. R&D Systems Company Details
Table 67. R&D Systems Business Overview
Table 68. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 69. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 70. R&D Systems SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 71. R&D Systems Recent Development
Table 72. Thermo Fisher Scientific Company Details
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 75. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 76. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 77. Thermo Fisher Scientific Recent Development
Table 78. Ortho Clinical Diagnostics Company Details
Table 79. Ortho Clinical Diagnostics Business Overview
Table 80. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 81. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 82. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 83. Ortho Clinical Diagnostics Recent Development
Table 84. BD Biosciences Company Details
Table 85. BD Biosciences Business Overview
Table 86. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 87. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 88. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 89. BD Biosciences Recent Development
Table 90. ZEUS Scientific Company Details
Table 91. ZEUS Scientific Business Overview
Table 92. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 93. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 94. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 95. ZEUS Scientific Recent Development
Table 96. Bio-Rad Laboratories Company Details
Table 97. Bio-Rad Laboratories Business Overview
Table 98. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 99. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 100. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 101. Bio-Rad Laboratories Recent Development
Table 102. ALPCO Company Details
Table 103. ALPCO Business Overview
Table 104. ALPCO SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 105. ALPCO SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 106. ALPCO SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 107. ALPCO Recent Development
Table 108. Enzo Life Sciences Company Details
Table 109. Enzo Life Sciences Business Overview
Table 110. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 111. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 112. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 113. Enzo Life Sciences Recent Development
Table 114. BioMérieux Company Details
Table 115. BioMérieux Business Overview
Table 116. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 117. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 118. BioMérieux SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 119. BioMérieux Recent Development
Table 120. LOEWE Biochemica Company Details
Table 121. LOEWE Biochemica Business Overview
Table 122. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 123. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 124. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA SWOT Analysis
Table 125. LOEWE Biochemica Recent Development
Table 126. Shenzhen YHLO Biotech Company Details
Table 127. Shenzhen YHLO Biotech Business Overview
Table 128. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 129. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 130. Shenzhen YHLO Biotech Recent Development
Table 131. LG Company Details
Table 132. LG Business Overview
Table 133. LG SARS-CoV-2 IgG (RBD) ELISA Product and Services
Table 134. LG SARS-CoV-2 IgG (RBD) ELISA Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024) & (US$ Million)
Table 135. LG Recent Development
Table 136. SARS-CoV-2 IgG (RBD) ELISA Market Trends
Table 137. SARS-CoV-2 IgG (RBD) ELISA Market Drivers
Table 138. SARS-CoV-2 IgG (RBD) ELISA Market Challenges
Table 139. SARS-CoV-2 IgG (RBD) ELISA Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. SARS-CoV-2 IgG (RBD) ELISA Product Picture
Figure 2. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Type: 2022 VS 2034
Figure 4. ELISA Sets Features
Figure 5. ELISA Kits Features
Figure 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 7. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Application: 2022 VS 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Disease control and prevention system
Figure 11. SARS-CoV-2 IgG (RBD) ELISA Report Years Considered
Figure 12. Global SARS-CoV-2 IgG (RBD) ELISA Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global SARS-CoV-2 IgG (RBD) ELISA Market Size 2018-2034 (US$ Million)
Figure 14. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Market Share by Region: 2022 VS 2034
Figure 15. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Region in 2018 VS 2022
Figure 16. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share Forecast by Region (2024-2034)
Figure 17. Global Top 10 SARS-CoV-2 IgG (RBD) ELISA Countries Ranking by Market Size (US$ Million) in 2022
Figure 18. Global SARS-CoV-2 IgG (RBD) ELISA Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 19. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Players in 2022
Figure 20. Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-CoV-2 IgG (RBD) ELISA as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by SARS-CoV-2 IgG (RBD) ELISA Revenue in 2022
Figure 22. North America SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Company in 2022
Figure 23. North America SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2018-2034)
Figure 24. North America SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2018-2034)
Figure 25. North America SARS-CoV-2 IgG (RBD) ELISA Revenue Share by Country (2018-2034)
Figure 26. United States SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 27. Canada SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 28. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Company in 2022
Figure 29. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2018-2034)
Figure 30. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2018-2034)
Figure 31. Europe SARS-CoV-2 IgG (RBD) ELISA Revenue Share by Country (2018-2034)
Figure 32. Germany SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 33. France SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 34. U.K. SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 35. Italy SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 36. Russia SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 37. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Company in 2022
Figure 38. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2018-2034)
Figure 39. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2018-2034)
Figure 40. Asia Pacific SARS-CoV-2 IgG (RBD) ELISA Revenue Share by Region (2018-2034)
Figure 41. China SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 42. Japan SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 43. South Korea SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 44. India SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 45. Australia SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 46. China Taiwan SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 47. Indonesia SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 48. Thailand SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 49. Malaysia SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 50. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Company in 2022
Figure 51. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2018-2034)
Figure 52. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2018-2034)
Figure 53. Latin America SARS-CoV-2 IgG (RBD) ELISA Revenue Share by Country (2018-2034)
Figure 54. Mexico SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 55. Brazil SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 56. Argentina SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 57. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Company in 2022
Figure 58. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2018-2034)
Figure 59. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2018-2034)
Figure 60. Middle East and Africa SARS-CoV-2 IgG (RBD) ELISA Revenue Share by Country (2018-2034)
Figure 61. Turkey SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 62. Saudi Arabia SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 63. UAE SARS-CoV-2 IgG (RBD) ELISA Revenue (2018-2034) & (US$ Million)
Figure 64. R&D Systems Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 66. Ortho Clinical Diagnostics Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 67. BD Biosciences Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 68. ZEUS Scientific Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 69. Bio-Rad Laboratories Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 70. ALPCO Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 71. Enzo Life Sciences Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 72. BioMérieux Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 73. LOEWE Biochemica Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 74. Shenzhen YHLO Biotech Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 75. LG Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed